$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Diets rich in saturated fatty acids such as palmitic acid (PA) have been linked to obesity and other comorbidities, including cardiovascular disease and diabetes1,2. High fat diets have also been shown to increase oxidative stress, apoptosis, and neuronal degeneration in the hypothalamus, an important regulator of appetite and energy expenditure3-7. Understanding the mechanism through which high fat diet exposure induces hypothalamic dysregulation is thus important for development of pharmacological treatments for obesity. However, the cellular mechanisms through which dietary fat affects neuronal function remain unclear. A better understanding of how fats such as PA might trigger onset of hypothalamic apoptotic pathways is a necessary first step toward this aim. The goal of this article is to describe a multiplex assay for in vitro testing of neuronal response to PA exposure, developed for use in studies of hypothalamic neurodegeneration. We provide a detailed description of an in vitro 96-well format multiplex assay for measuring caspase 3/7 activity per total number of cells in a differentiated immortalized adult mouse hypothalamic cell line (designated A12) after oxidative challenge with PA8.
Briefly, cell viability is determined following PA challenge via a resazurin based assay. Resazurin is a cell permeable compound that undergoes enzymatic reduction in metabolically active cells, a process thought to occur via the mitochondria9. Viable cells continuously convert resazurin to resorufin, producing a fluorescent signal proportional to the number of viable cells. Caspase-3/7 activity is then analyzed using a DEVD-based lumogenic assay. DEVD is an amino acid sequence (Asp-Glu-Val-Asp) cleaved by caspase-3. When this sequence is coupled to a lumogenic substance, upon activation of intracellular caspase-3/7 and subsequent cleavage of DEVD substrate, the luminescent product is released. This reaction is proportional to caspase activity and thus to the induction of apoptosis. As dead cells cannot produce caspase, caspase-3/7 activity is by nature transient; therefore analysis should be completed between 30 min to 4 hr post-challenge, depending on effectiveness of cell stressor. Cell viability is inversely proportional to caspase-3/7 activity and can be used to determine mechanisms of cell death. For example, this method has previously been used to show that pretreatment with the peptide hormone orexin reduces apoptosis in hypothalamic cells challenged with hydrogen peroxide, suggesting that mechanisms affected by this treatment are important in protecting against oxidative damage10. It is important to note these assays are cell line- and tissue-dependent, as they rely upon mitochondrial activity to reduce assay reagents. This protocol has been optimized for adult mouse hypothalamic (A12) cells; however, methods described may be altered to fit within the scope of similar research.
Multiplexing assays from a single culture well provides an advantage over the traditional method of performing individual assays for several reasons. In addition to saving time, cell samples, and culture reagents, multiplexing assays can also provide knowledge of cell survival and death, provide internal controls, and eliminate the need for repetitive experiments11,12.
Alternative methods have relied upon Western blots or ELISAs, which are reliable assays, but are expensive and time consuming (1-2 days), especially when using a 96-well format. Excluding the time it takes to culture cells for the multiplexing assay, the total time is less than 3 hr. While this protocol has been optimized for use with A12 cells, it may be altered for use in other models while keeping in mind factors that may influence cell integrity. Determining if this protocol would work for a series of experiments depends upon on the number of samples or experimental conditions and on planned downstream experiments.